Tyra Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84.96	77.39	91.97	58.01	251.21	302.18
Short-Term Investments	298.51	178.62	249.48	145.46	-	-
Cash & Short-Term Investments	383.47	256	341.44	203.47	251.21	302.18
Cash Growth	20.23%	-25.02%	67.81%	-19.00%	-16.87%	1884.90%
Other Current Assets	11.15	9.45	6.02	8.2	6.08	1.88
Total Current Assets	394.61	265.45	347.46	211.67	257.29	304.06
Net Property, Plant & Equipment	6.66	6.89	7.72	8.15	3.54	2.09
Other Long-Term Assets	10.77	10.27	8.38	6.03	5.35	0.56
Total Assets	412.04	282.61	363.56	225.86	266.18	306.7
Accounts Payable	3.64	1.18	0.59	4.66	1.15	0.6
Accrued Expenses	15.13	16.44	13.59	10.39	4.42	2.82
Current Portion of Leases	0.49	0.47	0.41	0.28	0.14	0.2
Total Current Liabilities	19.26	18.09	14.59	15.33	5.7	3.62
Long-Term Leases	5.21	5.34	5.81	6.22	2.48	0.98
Other Long-Term Liabilities	-	-	0	0.05	0.17	0.37
Total Long-Term Liabilities	5.21	5.34	5.81	6.26	2.65	1.35
Total Liabilities	24.47	23.43	20.41	21.6	8.35	4.96
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-in Capital	798.03	630.04	593.69	368.71	353.52	342.1
Accumulated Other Comprehensive Income	0.11	0.39	0.77	0.38	-	-
Retained Earnings	-	-371.26	-251.31	-164.83	-95.7	-40.37
Total Common Shareholders' Equity	387.58	259.18	343.15	204.26	257.83	301.74
Shareholders' Equity	387.58	259.18	343.15	204.26	257.83	301.74
Total Liabilities & Equity	412.04	282.61	363.56	225.86	266.18	306.7
Total Debt	5.7	5.81	6.22	6.5	2.62	1.18
Net Cash (Debt)	377.77	250.19	335.22	196.97	248.59	301
Net Cash Growth	50.99%	-25.36%	70.19%	-20.76%	-17.41%	1895.75%
Net Cash Per Share	6.28	4.20	5.86	4.61	5.93	21.84
Book Value	387.58	259.18	343.15	204.26	257.83	301.74
Book Value Per Share	6.44	4.35	6.00	4.78	6.16	21.90
Tangible Book Value	387.58	259.18	343.15	204.26	257.83	301.74
Tangible Book Value Per Share	6.44	4.35	6.00	4.78	6.16	21.90

SEC Filings: 10-K · 10-Q